儿童急性血源性骨髓炎全身抗生素治疗的研究进展
DOI:
作者:
作者单位:

1.甘肃中医药大学第一临床医学院;2.解放军联勤保障部队第九四〇医院创伤骨科

作者简介:

通讯作者:

中图分类号:

基金项目:


Research advances in systemic antibiotic treatment of acute hematogenous osteomyelitis in children
Author:
Affiliation:

1.First Clinical Medical College of Gansu University of Chinese Medicine;2.Department of Traumatic Orthopedics,The 940th Hospital of the PLA Joint Logistic Support Force

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    急性血源性骨髓炎(acute hematogenous osteomyelitis,AHO)是儿童骨关节感染中最常见的类型之一。及时准确地诊断和早期有效地抗菌治疗是患儿获得良好预后的关键。抗生素的合理使用在该病的治疗中扮演着重要角色。有关抗生素的选择、给药方式及用药疗程等方面,需根据当地的流行病学及耐药模式、疾病的严重程度、致病菌毒力、患儿的基础疾病与免疫状态及其对治疗的反应等诸多因素进行个体化制定。此外,在过去的十几年里,该病的流行病学发生了迅速变化,特别是耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus,MRSA)引起的感染,对治疗提出了新的挑战。

    Abstract:

    Acute hematogenous osteomyelitis(AHO)is one of the most common types of bone and joint infection in children.Timely and accurate diagnosis and early effective antibacterial treatment are the key to a good prognosis of children.The rational use of antibiotics plays an important role in the treatment of the disease.About the choice of antibiotics,the mode of administration and the course of treatment,it should be individualized according to the local epidemiology and drug resistance model,the severity of the disease,the virulence of pathogenic bacteria,the underlying diseases and immunity of children and their response to treatment.In addition,the epidemiology of the disease has changed rapidly in the past decade,especially the infection caused by methicillin-resistant Staphylococcus aureus(MRSA),which poses a new challenge to the treatment.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-12-08
  • 最后修改日期:2022-04-24
  • 录用日期:2022-08-16
  • 在线发布日期:
  • 出版日期: